English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

An aortic stentless bioprosthesis (Biocor Ind.) was implanted in 17 patients with difficult aortic annulus due either to endocarditis orto a previous aortic valve replacement. Native valve endocarditis was present in 3 patients and prosthetic valve endocarditis in 5; 9 patients had one or more previous aortic valve replacements showing a wheakened aortic rim. The stentless bioprosthesis was implanted with a two layers suture technique similar to a homograft implant. The ascending aorta was enlarged with a patch of bovine pericardium in 11 ocasions; mitral valve replacement was concomitantly performed in 3 patients. There was one hospital death secondary to multiple organ failure in a patient with acute endocarditis and a preoperative cerebro-vascular accident. One patient who was pacemaker dependant had a sudden death in the 6 th postoperative month. All other 15 patients are in regular follow-up with periodic ecocardiographic analysis. One patient had partial deiscense of the lower suture line which generated a gradient in the left ventricular outflow tract; he was reoperated upon and the valve was refixed with flow normalization. In all patients the valve has shown an excellent performance with very small gradients (mean = 10.6 mmHg) and abscence of significant aortic regurgitation. No case of reinfection was observed in the patients with endocarditis. The stentless aortic bioprosthesis proved to be an excellent heart valve substitute in this difficult group of patients.

Implante de bioprótese aórtica "stentless" em pacientes com alterações do anel aórtico